These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 36979409)

  • 1. Solid-State Preparation and Characterization of 2-Hydroxypropylcyclodextrins-Iodine Complexes as Stable Iodophors.
    Dattilo S; Spitaleri F; Aleo D; Saita MG; Patti A
    Biomolecules; 2023 Mar; 13(3):. PubMed ID: 36979409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel cationic β-cyclodextrin decorated with a choline-like pendant exhibits Iodophor, Mucoadhesive and bactericidal properties.
    Pedotti S; Ferreri L; Migliore R; Leotta CG; Pitari GM; D'Antona N; Petralia S; Aleo D; Sgarlata C; Consoli GML
    Carbohydr Polym; 2024 Mar; 328():121698. PubMed ID: 38220321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation and characterization of inclusion complexes formed between baicalein and cyclodextrins.
    Zhou Q; Wei X; Dou W; Chou G; Wang Z
    Carbohydr Polym; 2013 Jun; 95(2):733-9. PubMed ID: 23648035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physicochemical characterization and in vitro biological evaluation of solid compounds from furazolidone-based cyclodextrins for use as leishmanicidal agents.
    Carvalho SG; Cipriano DF; de Freitas JCC; Junior MÂS; Ocaris ERY; Teles CBG; de Jesus Gouveia A; Rodrigues RP; Zanini MS; Villanova JCO
    Drug Deliv Transl Res; 2020 Dec; 10(6):1788-1809. PubMed ID: 32803562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation and characterization of the inclusion complex of furosemide with hydroxypropyl-beta-cyclodextrin.
    Vlachou M; Papaïoannou G
    J Biomater Appl; 2003 Jan; 17(3):197-206. PubMed ID: 12614084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The physicochemical characteristics and bioavailability of indomethacin from beta-cyclodextrin, hydroxyethyl-beta-cyclodextrin, and hydroxypropyl-beta-cyclodextrin complexes.
    Jambhekar S; Casella R; Maher T
    Int J Pharm; 2004 Feb; 270(1-2):149-66. PubMed ID: 14726131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement of water solubility of sulfamethizole through its complexation with beta- and hydroxypropyl-beta-cyclodextrin. Characterization of the interaction in solution and in solid state.
    Pose-Vilarnovo B; Perdomo-López I; Echezarreta-López M; Schroth-Pardo P; Estrada E; Torres-Labandeira JJ
    Eur J Pharm Sci; 2001 Jun; 13(3):325-31. PubMed ID: 11384856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydroxypropylcyclodextrins in parenteral use. I: Lipid dissolution and effects on lipid transfers in vitro.
    Irie T; Fukunaga K; Pitha J
    J Pharm Sci; 1992 Jun; 81(6):521-3. PubMed ID: 1522487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solubility and dissolution rate of progesterone-cyclodextrin-polymer systems.
    Lahiani-Skiba M; Barbot C; Bounoure F; Joudieh S; Skiba M
    Drug Dev Ind Pharm; 2006 Oct; 32(9):1043-58. PubMed ID: 17012117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solid-state characterization and in vitro dissolution behavior of lorazepam: Hydroxypropyl-β-cyclodextrin inclusion complex.
    Patel R; Patel M
    Drug Discov Ther; 2010 Dec; 4(6):442-52. PubMed ID: 22491310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement in solubility and dissolution rate of 1, 2-dithiole-3-thiones upon complexation with beta-cyclodextrin and its hydroxypropyl and sulfobutyl ether-7 derivatives.
    Dollo G; Le Corre P; Chollet M; Chevanne F; Bertault M; Burgot JL; Le Verge R
    J Pharm Sci; 1999 Sep; 88(9):889-95. PubMed ID: 10479350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physico-chemical characterization in solution and in the solid state of clonazepam complexes with native and chemically-modified cyclodextrins.
    Mennini N; Bragagni M; Maestrelli F; Mura P
    J Pharm Biomed Anal; 2014 Feb; 89():142-9. PubMed ID: 24291109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physico-chemical characterization and in vitro dissolution assessment of clonazepam-cyclodextrins inclusion compounds.
    Patel R; Purohit N
    AAPS PharmSciTech; 2009; 10(4):1301-12. PubMed ID: 19885735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nootkatone encapsulation by cyclodextrins: Effect on water solubility and photostability.
    Kfoury M; Landy D; Ruellan S; Auezova L; Greige-Gerges H; Fourmentin S
    Food Chem; 2017 Dec; 236():41-48. PubMed ID: 28624088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of inclusion complex of epothilone A with cyclodextrins.
    Xiao CF; Li K; Huang R; He GJ; Zhang JQ; Zhu L; Yang QY; Jiang KM; Jin Y; Lin J
    Carbohydr Polym; 2014 Feb; 102():297-305. PubMed ID: 24507285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of oral bioavailability of cilostazol by forming its inclusion complexes.
    Patel SG; Rajput SJ
    AAPS PharmSciTech; 2009; 10(2):660-9. PubMed ID: 19459053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complexation of the interferon inducer, bropirimine, with hydroxypropyl-beta-cyclodextrin.
    Echezarreta-López M; Torres-Labandeira JJ; Castiñeiras-Seijo L; Santana-Penín L; Vila-Jato JL
    Eur J Pharm Sci; 2000 Feb; 9(4):381-6. PubMed ID: 10664478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of tolbutamide-hydroxypropyl-gamma-cyclodextrin interaction in solution and solid state.
    Veiga MD; Ahsan F
    Chem Pharm Bull (Tokyo); 2000 Jun; 48(6):793-7. PubMed ID: 10866138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
    Badr-Eldin SM; Elkheshen SA; Ghorab MM
    Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of inclusion complexation with cyclodextrins on photostability of nifedipine in solid state.
    Bayomi MA; Abanumay KA; Al-Angary AA
    Int J Pharm; 2002 Aug; 243(1-2):107-17. PubMed ID: 12176299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.